Schleimer Karina, Stippel Dirk L, Kasper Hans-U, Suer Christian, Tawadros Samir, Hölscher Arnulf H, Beckurts Tobias E
Department of Visceral and Vascular Surgery, University of Cologne, Cologne, Germany.
Med Sci Monit. 2006 Apr;12(4):BR140-5. Epub 2006 Mar 28.
Clinical experience with portal vein arterialization (PVA) in liver transplantation is controversial. One reason for this is the lack of standardized flow regulation. The present experiments aimed to establish flow regulation in the arterialized portal vein for heterotopic auxiliary liver transplantation (HALT), to obtain physiological portal blood flow, and to compare this technique with orthotopic liver transplantation.
MATERIAL/METHODS: Lewis rats were divided into 7 groups (n = 8 transplantations/group). Group: A I-IV: In HALT, the portal vein was anastomosed to the right renal artery using stents with different diameters (0.2, 0.3, 0.4, 0.5 mm). Afterwards, HALT with PVA using the stent diameter that had achieved the most physiological portal blood flow (group B II) was compared with orthotopic liver transplantation with porto-portal anastomosis (group B III) and to the sham group (B I).
After reperfusion, only the 0.3 mm stent resulted in an average blood flow in the arterialized portal vein in HALT which was within the normal range (1.7+/-0.4 ml/min/g liver weight). The parameters of microcirculation and early graft function were significantly better in group B II than in group B III (functional sinusoidal density: 335+/-48 vs. 224+/-31/cm, diameter of sinusoids: 6.4+/-0.6 vs. 5.2+/-0.6 microm, diameter of postsinusoidal venules: 31.1+/-3.3 vs. 25.5+/-2.0 microm, bile-production: 27+/-8 vs. 19+/-5 microl/h/g liver weight).
Using an optimal stent diameter in HALT with portal vein arterialization, an adequate flow-regulation can be achieved. Avoiding portal hyper- and hypoperfusion, good results for microcirculation and early graft function can be obtained.
肝移植中门静脉动脉化(PVA)的临床经验存在争议。原因之一是缺乏标准化的血流调节。本实验旨在为异位辅助肝移植(HALT)建立动脉化门静脉的血流调节,以获得生理性门静脉血流,并将该技术与原位肝移植进行比较。
材料/方法:将Lewis大鼠分为7组(每组n = 8次移植)。分组:A I-IV:在HALT中,使用不同直径(0.2、0.3、0.4、0.5毫米)的支架将门静脉与右肾动脉吻合。之后,将使用已实现最生理性门静脉血流的支架直径进行PVA的HALT(B II组)与采用门静脉-门静脉吻合的原位肝移植(B III组)以及假手术组(B I组)进行比较。
再灌注后,仅0.3毫米的支架使HALT中动脉化门静脉的平均血流处于正常范围内(1.7±0.4毫升/分钟/克肝脏重量)。B II组的微循环参数和早期移植物功能明显优于B III组(功能性肝血窦密度:335±48对224±31/平方厘米,肝血窦直径:6.4±0.6对5.2±0.6微米,肝血窦后小静脉直径:31.1±3.3对25.5±2.0微米,胆汁生成:27±8对19±5微升/小时/克肝脏重量)。
在门静脉动脉化的HALT中使用最佳支架直径,可实现充分的血流调节。避免门静脉灌注过多和过少,可获得良好的微循环和早期移植物功能结果。